Natural biological probiotic products company Terragen is raising $20 million for its initial public offering.
The company, which makes products for crops and animals, will list with a $46.6m market value.
Shares will be sold at 25c each and the company plans to launch its book build on October 16 and list on December 11.
Working on the deal is Bell Potter and Evans Dixon.
Terragen describes itself as a company that provides a new approach to natural probiotic products. It says it helps farmers increase productivity and reduce reliance on chemical-based fertilisers, pesticides and antibiotics.
It has developed and commercialised on a cost competitive basis a portfolio of natural biological probiotic products for crops and animals.
Products are distributed across Australia and New Zealand.
Add your comment to this story
Webjet block trade outcome puzzles investors
A suitor looking for 5 per cent of the shares in the online travel group has come up short.
Regis Healthcare co-founder offloads 5pc stake
Bryan Dorman is selling a $108m holding in the company through investment bank Jarden with shares were being offered at $7.18.
To join the conversation, please log in. Don't have an account? Register
Join the conversation, you are commenting as Logout